Insider Stock Trading History of Vitullo Nicole


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Vitullo Nicole since year 2005. The trader's CIK number is 1196863. At the time of this reporting, Vitullo Nicole is the Director of Achillion Pharmaceuticals Inc . (stock ticker symbol ACHN). See this page for all insider trading activities at Achillion Pharmaceuticals Inc .

Note that in the past VITULLO NICOLE also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Vitullo Nicole since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-10 ACHN Achillion Pharmaceuticals Inc Option Ex 2,811,245 3.11 8,751,405
2016-08-03 CLCD Colucid Pharmaceuticals, Inc. Sale 81,094 8.15 660,916
2016-08-02 CLCD Colucid Pharmaceuticals, Inc. Sale 19,718 8.71 171,743
2016-08-01 CLCD Colucid Pharmaceuticals, Inc. Sale 52,216 8.82 460,545
2016-08-03 CLCD Colucid Pharmaceuticals, Inc. Sale 129 8.15 1,051
2016-08-02 CLCD Colucid Pharmaceuticals, Inc. Sale 32 8.71 278
2016-08-01 CLCD Colucid Pharmaceuticals, Inc. Sale 84 8.82 740
2016-04-28 CLCD Colucid Pharmaceuticals, Inc. Sale 149,765 6.96 1,042,364
2016-04-28 CLCD Colucid Pharmaceuticals, Inc. Sale 235 6.96 1,635
2015-11-09 ACHN Achillion Pharmaceuticals Inc Sale 320,926 10.01 3,212,469
2015-11-10 ACHN Achillion Pharmaceuticals Inc Sale 179,074 10.43 1,867,741
2015-11-11 ACHN Achillion Pharmaceuticals Inc Sale 50,000 10.31 515,500
2015-09-25 ACHN Achillion Pharmaceuticals Inc Sale 9,310 8.22 76,528
2015-08-14 ACHN Achillion Pharmaceuticals Inc Sale 37,843 7.51 284,200
2014-08-05 MRNS Marinus Pharmaceuticals Inc Buy 419,744 8.00 3,357,952
2014-05-01 ALDX Aldeyra Therapeutics, Inc. Option Ex 121,152 5.16 625,144
2013-08-27 RGDO Regado Biosciences Inc Buy 750,000 4.00 3,000,000
2013-07-15 OCRX Tranzyme Inc Buy 1,327,491 6.03 7,999,460
2013-07-01 ESPR Esperion Therapeutics, Inc. Buy 285,714 14.00 3,999,996
2012-07-24 DRTX Durata Therapeutics, Inc. Buy 784,313 9.00 7,058,817
2011-12-22 OREX Orexigen Therapeutics, Inc. Buy 469,147 1.45 680,263
2011-11-21 CLVS Clovis Oncology, Inc. Buy 931,683 13.00 12,111,879
2011-09-16 ZGNX Zogenix, Inc. Buy 3,500,000 2.00 7,000,000
2011-06-02 ALIM Alimera Sciences Inc Sale 6,914 8.04 55,588
2010-11-29 ZGNX Zogenix, Inc. Buy 2,349,999 4.00 9,399,996
2010-10-06 ACHN Achillion Pharmaceuticals Inc Option Ex 25,000 3.02 75,500
2010-04-27 ALIM Alimera Sciences Inc Buy 378,028 11.00 4,158,308
2009-12-17 OREX Orexigen Therapeutics, Inc. Buy 100,000 7.55 755,000
2009-12-18 OREX Orexigen Therapeutics, Inc. Buy 38,100 7.50 285,750
2009-11-24 OREX Orexigen Therapeutics, Inc. Buy 50,000 6.75 337,500
2009-11-20 OREX Orexigen Therapeutics, Inc. Buy 250,000 6.93 1,732,500
2009-11-23 OREX Orexigen Therapeutics, Inc. Buy 150,000 6.93 1,039,500
2009-11-12 OREX Orexigen Therapeutics, Inc. Buy 62,000 6.90 427,800
2009-11-10 OREX Orexigen Therapeutics, Inc. Buy 84,400 6.93 584,892
2009-11-11 OREX Orexigen Therapeutics, Inc. Buy 53,600 6.93 371,448
2009-08-18 OREX Orexigen Therapeutics, Inc. Buy 13,784 7.73 106,550
2009-08-14 OREX Orexigen Therapeutics, Inc. Buy 26,225 8.00 209,800
2009-08-17 OREX Orexigen Therapeutics, Inc. Buy 63,201 7.64 482,855
2009-08-12 OREX Orexigen Therapeutics, Inc. Buy 400,000 8.00 3,200,000
2009-08-13 OREX Orexigen Therapeutics, Inc. Buy 13,000 7.85 102,050
2009-08-11 OREX Orexigen Therapeutics, Inc. Buy 104,300 7.60 792,680
2009-07-23 OREX Orexigen Therapeutics, Inc. Buy 650,000 7.50 4,875,000
2009-02-18 CADX Cadence Pharmaceuticals Inc Buy 2,780,674 7.13 19,826,205
2008-12-08 OREX Orexigen Therapeutics, Inc. Buy 248,411 4.47 1,110,397
2008-12-09 OREX Orexigen Therapeutics, Inc. Buy 241,890 4.93 1,192,517
2006-12-21 SOMX Somaxon Pharmaceuticals, Inc. Sale 6,459 13.52 87,325
2006-12-12 VNDA Vanda Pharmaceuticals Inc. Sale 12,900 25.62 330,498
2006-09-18 SOMX Somaxon Pharmaceuticals, Inc. Sale 6,459 13.03 84,160

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vitullo Nicole (Director of Achillion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.